Philip Morris International to Report Q3 2026 Results, Highlighting Smoke-Free Transition

  • Philip Morris International (PMI) will host a live webcast on October 21, 2026, at 9:00 a.m. ET to discuss its Q3 2026 and first nine-months financial results.
  • The webcast will be hosted by Massimo Andolina, Group Chief Financial Officer, and will include a Q&A session with the investment community.
  • PMI's smoke-free products accounted for approximately 42% of its second-quarter 2026 total net revenues.
  • The company has invested over $16 billion since 2008 to develop and commercialize smoke-free products.
  • The U.S. FDA has authorized the marketing of Swedish Match’s General snus, ZYN nicotine pouches, and versions of PMI’s IQOS devices and consumables.

PMI's strategic shift towards smoke-free products is part of a broader industry trend away from traditional tobacco. The company's significant investment in R&D and regulatory approvals positions it as a leader in the smoke-free category. The upcoming earnings call will provide insights into the financial viability of this transition and the company's long-term ambitions in wellness areas.

Revenue Transition
How the 42% revenue share from smoke-free products will evolve in Q3 2026 and whether PMI can sustain this growth trajectory.
Regulatory Dynamics
The impact of FDA authorizations on PMI's market expansion and the pace at which other regulators may follow suit.
Execution Risk
Whether PMI can successfully transition its consumer base from traditional cigarettes to smoke-free alternatives.